Molecular Drivers of Cardiomyocyte Maturation

Establishing cardiomyocytes derived from human induced pluripotent stem cells has great potential as a cell source for therapeutic applications, such as regenerative medicine. Discover the latest research on Molecular Drivers of Cardiomyocyte Maturation here.

June 26, 2020
Open Access

B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells

Frontiers in Immunology
Marta MagattiOrnella Parolini
July 11, 2020

Arsenic Directs Stem Cell Fate by Imparting Notch Signaling into the Extracellular Matrix Niche

Toxicological Sciences : an Official Journal of the Society of Toxicology
Teresa AnguianoAaron Barchowsky
July 1, 2020

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Journal of Visualized Experiments : JoVE
Takeichiro NakaneHidetoshi Masumoto
June 20, 2020
Open Access

Pax7 as molecular switch regulating early and advanced stages of myogenic mouse ESC differentiation in teratomas

Stem Cell Research & Therapy
Anita FlorkowskaIwona Grabowska
July 11, 2020

Sustained Activation of AMPK Enhances Differentiation of Human iPSC-Derived Cardiomyocytes via Sirtuin Activation

Stem Cell Reports
Mohsen SarikhaniRichard T Lee
July 1, 2020

Evaluation of Osteogenic/Cementogenic Modulating Potential of PAI-1 Transfected Media for Stem Cells

IEEE Transactions on Nanobioscience
Hexiu JinKi-Taek Lim
June 23, 2020

Silencing of MYH7 ameliorates disease phenotypes in human iPSC-Cardiomyocytes

Physiological Genomics
Alexandra DainisEuan A Ashley
June 21, 2020
Open Access

Pluripotent Stem Cell Modeling of Anticancer Therapy-Induced Cardiotoxicity

Current Cardiology Reports
Davi M Lyra-Leite, Paul W Burridge
June 24, 2020

The role of molecular mechanism of Ten-Eleven Translocation2 (TET2) family proteins in pathogenesis of cardiovascular diseases (CVDs)

Molecular Biology Reports
Fatemeh Javaherforoosh ZadehHadi Rezaeeyan
June 13, 2020

Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics

Journal of Molecular and Cellular Cardiology
Jamie R BhagwanChris Denning
June 24, 2020
Open Access

p38 mitogen-activated protein kinase regulates chamber specific perinatal growth in heart

The Journal of Clinical Investigation
Tomohiro YokotaYibin Wang
June 21, 2020

Modeling Congenital Heart Disease Using Pluripotent Stem Cells

Current Cardiology Reports
Arun Sharma
June 12, 2020

Oxygen homeostasis and cardiovascular disease: A role for HIF?

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Xinyu LiMingyi Zhao
July 4, 2020

Bufalin-induced cardiotoxicity: new findings into mechanisms

Chinese Journal of Natural Medicines
Min LiJing Ma
June 25, 2020
Open Access

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges

International Journal of Molecular Sciences
Elvira Immacolata ParrottaGiovanni Cuda

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

© 2020 Meta ULC. All rights reserved